1-3
2026
影响因子区间
—
平台估算
14%
2025
中国作者发文占比
—
收费
期刊简介:Clinical and Experimental Otorhinolaryngology (Clin Exp Otorhinolaryngol, CEO) is an international peer-reviewed journal on recent developments in diagnosis and treatment of otorhinolaryngology-head and neck surgery and dedicated to the advancement of patient care in ear, nose, throat, head, and neck disorders. This journal publishes original articles relating to both clinical and basic researches, reviews, and clinical trials, encompassing the whole topics of otorhinolaryngology-head and neck surgery.CEO was first issued in 2008 and this journal is published in English four times (the last day of February, May, August, and November) per year by the Korean Society of Otorhinolaryngology-Head and Neck Surgery. The Journal aims at publishing evidence-based, scientifically written articles from different disciplines of otorhinolaryngology field.The readership contains clinical/basic research into current practice in otorhinolaryngology, audiology, speech pathology, head and neck oncology, plastic and reconstructive surgery. The readers are otolaryngologists, head and neck surgeons and oncologists, audiologists, and speech pathologists.
【译文】临床与实验耳鼻喉科(临床实验耳鼻喉科,CEO)是一本关于耳鼻喉科-头颈外科诊断和治疗最新发展的国际同行评审期刊,致力于提高耳鼻喉、头颈疾病的护理水平。该期刊发表与临床和基础研究、综述和临床试验相关的原创文章,涵盖耳鼻喉科-头颈外科的整个主题。CEO首次发行于2008年,该期刊由韩国耳鼻喉科-头颈外科协会每年用英语出版四次(二月、五月、八月和十一月的最后一天)。该期刊旨在出版来自耳鼻喉科领域的不同学科的基于证据、科学撰写的文章。读者包括耳鼻喉科、头颈外科和肿瘤科医生,听力学家和言语病理学家。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |